Back to search

Article

ADAR1 editing dependency in triple-negative breast cancer

2020-02-02

Abstract excerpt

<h4>Summary</h4> Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other types of breast cancer that can be effectively treated by targeted therapies, no such targeted therapy exists for all TNBC patients. The ADAR1 enzyme carries out A-to-I editing of RNA to prevent sensing of cellular double-stranded RNAs (dsRNA). ADAR1 is highly expressed in breast cancer including TNBC. Here,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
95257e81-8f25-5874-8a40-c0d4a8f14ac3
DOI
10.1101/2020.01.31.928911
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ADAR1 editing dependency in triple-negative breast cancerDOI 10.1101/2020.01.31.928911
Select a neighboring publication to make it the new centre.